Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Anal Cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines

Published in 2014 – Ann Oncol (2014) 25 (suppl 3): iii10-iii20.
Authors: R. Glynne-Jones, P. J. Nilsson, C. Aschele, V. Goh, D. Peiffert, A. Cervantes, and D. Arnold

Squamous cell carcinoma of the anus (SCCA) is strongly associated with human papillomavirus (HPV) infection which represents the causative agent in 80%–85% of patients (usually from HPV16 or HPV18 subtypes in Europe) as is its precursor lesion anal intra-epithelial neoplasia (AIN) 3. This ESMO-ESSO-ESTRO Guideline gives information on the incidence and epidemiology, diagnosis, screening, pathology and molecular biology of the disease as well as current treatment options and follow-up.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings